AI-Powered Urine Test Can Predict COPD Flare-Ups Up to a Week before they Occur

Scientists have created a urine-based test using artificial intelligence (AI) to forecast worsening symptoms of chronic obstructive pulmonary disease (COPD) up to a week before they manifest. This advancement could enable early intervention to prevent severe episodes in COPD patients.

Published in ERJ Open Research | Estimated reading time: 6 minutes

COPD, which includes conditions like chronic bronchitis and emphysema, affects millions globally and ranks as the third leading cause of death worldwide according to the World Health Organization. Exacerbations or flare-ups can significantly worsen symptoms such as coughing and breathing difficulties, sometimes resulting in hospitalization or irreversible lung damage.

To tackle this issue, researchers from the University of Leicester, UK, devised a test to measure levels of five biomarkers in urine samples. Patients conducted quick dipstick tests at home daily and shared their results through a mobile app. AI analysis of this data enabled researchers to predict symptom exacerbations roughly seven days in advance.

Professor Chris Brightling, who spearheaded the study, explained, “COPD exacerbations occur when a COPD patient gets very sick and requires extra treatment either at home or in the hospital. It would be beneficial if we could forecast an exacerbation before it happens and tailor treatment to prevent or lessen its impact.”

The research comprised two phases: first, identifying biomarkers associated with COPD flare-ups through analysis of urine samples from 55 patients, followed by monitoring 105 patients daily for six months using the newly developed test. By utilizing an artificial neural network (ANN) to detect changes in these biomarkers, researchers achieved a prediction accuracy with a median lead time of seven days.

Emphasizing the convenience of the test, Professor Brightling stated, “The advantage of urine sampling is that it’s relatively quick and easy for patients to perform at home on a daily basis.” He suggested that refining the AI tool with data from more patients could boost its reliability, potentially leading to personalized care that minimizes exposure to triggers like pollution or allergens.

While the outcomes are promising, the study underscores the necessity for larger trials to validate the AI model and integrate it into clinical settings. If successful, this approach could significantly enhance the quality of life for COPD patients by enabling proactive, personalized care.

Glossary

• COPD: Chronic obstructive pulmonary disease, a progressive lung condition causing breathing difficulties.
• Biomarkers: Biological molecules indicating a normal or pathological state, used for diagnosis or prognosis.
• Artificial Neural Network (ANN): A type of AI modeled after the human brain, used for recognizing patterns and making predictions.
• Exacerbation: A worsening or flare-up of symptoms in chronic diseases like COPD.
• Dipstick Test: A simple diagnostic tool that measures specific substances in bodily fluids like urine.

Related